2025 annual financial data
Rigel Pharmaceuticals 2025 Operating margin
Rigel Pharmaceuticals 2025 operating margin with verified reported values.
Direct answer
Operating margin was 42.63%.
Operating income was 125,466,000 USD and net income was 367,024,000 USD.
Operating cash flow was 75,655,000 USD.
Get free Rigel Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 294,282,000 USD
- Operating income
- 125,466,000 USD
- Net income
- 367,024,000 USD
- Operating cash flow
- 75,655,000 USD